Stay updated on ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page.

Latest updates to the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6 on the page. This signals a small maintenance update, with no indicated changes to the study details or user-facing information.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a small, non-substantive update to the entry. This likely reflects metadata or formatting adjustments rather than changes to the study details.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This is a minor platform update and does not alter study data or user-facing content.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous v3.6.0 tag. This signals a minor update to the page rather than a change to the study content.SummaryDifference0.0%

- Check91 days agoChange DetectedThe recruitment status now indicates the study is not enrolling participants, and new navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study). Additionally, the Intervention/Treatment heading formatting was adjusted and the site revision note updated to Revision: v3.6.0 (replacing v3.5.5).SummaryDifference0.3%

- Check98 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a minor administrative update to the page. This change does not affect the study content or displayed data.SummaryDifference0.0%

Stay in the know with updates to ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page.